The efficacy of rifapentine, an oral antibiotic used in the treatment of tuberculosis, is reduced due to its degradation at gastric pH and low solubility at intestinal pH. We aimed to improve delivery properties in vitro by incorporating rifapentine into pH-responsive amorphous solid dispersions with cellulose derivatives including: hydroxypropylmethylcellulose acetate succinate (HPMCAS), cellulose acetate suberate (CASub), and 5-carboxypentyl hydroxypropyl cellulose (CHC). Most amorphous solid dispersions reduced rifapentine release at gastric pH, with the best performing polymer CASub showing >31-fold decrease in area under the curve compared to rifapentine alone. Lower solubility at gastric conditions was accompanied by a reduction in the acidic degradation product 3-formylrifamycin, as compared to rifapentine alone. Certain formulations also showed enhanced apparent solubility and stabilization of supersaturated solutions at intestinal pH, with the best performing polymer HPMCAS showing almost a 4-fold increase in total area under the curve compared to rifapentine alone. These in vitro results suggest that delivery of rifapentine via amorphous solid dispersion with cellulose polymers may improve bioavailability in vivo. / Master of Science in Life Sciences / Rifapentine is an antibiotic that is used in the treatment of tuberculosis. Although it is an effective drug, it has limitations caused by digestion and its low ability to dissolve in water. The environment of the human stomach, which contains strong acid, can destroy the drug making it ineffective against the bacteria that cause tuberculosis. The low ability to dissolve in water is also a problem because in order for the drug to be absorbed, it must be dissolved first. Improving these characteristics of this drug could lead to advancements in the treatment and elimination of tuberculosis. The strategy we used to enhance the characteristics of this drug is called amorphous solid dispersion. This system holds the drug in a very easy to absorb form and releases it as such. Many amorphous solid dispersion formulations in combination with other drugs have shown improved ability to dissolve the drugs and protection of drugs from destruction in harsh conditions such as the stomach acid. Various derivatives of natural cellulose (a chain of sugars, called a polysaccharide, which is a major component of all plants) were used as part of this system, to stabilize the drug and to help dissolve it. We found that these amorphous solid dispersions did help to release and dissolve the drug in large concentrations and protect the drug from the stomach acid. Since we have seen positive results here, the next step is to use these systems in an animal study.

Made available in DSpace on 2014-12-17T14:16:37Z (GMT). No. of bitstreams: 1 DayanneLP_DISSERT.pdf: 9773593 bytes, checksum: c2be9b4f3b701218666100df5b460f30 (MD5) Previous issue date: 2014-03-24 / Since its synthesis over 48 years rifampicin has been extensively studied. The literature reports the characterization of thermal events for rifampicin in nitrogen atmosphere, however, no characterization in synthetic air atmosphere. This paper aims to contribute to the thermal study of rifampicin through thermal (TG / DTG, DTA, DSC and DSC - FOTOVISUAL ) and non-thermal (HPLC, XRPD , IR - FTIR , PCA) and its main degradation products ( rifampicin quinone , rifampicin N-oxide 3- formylrifamicin). Rifampicin study was characterized as polymorph form II from techniques DSC, IR and XRPD. TG curves for rifampicin in synthetic air atmosphere showed higher thermal stability than those in N2, when analyzed Ti and Ea. There was characterized as overlapping events melting and recrystallization under N2 with weight loss in the TG curve, suggesting concomitant decomposition. Images DSCFotovisual showed no fusion event and showed darkening of the sample during analysis. The DTA curve in synthetic air atmosphere was visually different from DTA and DSC curves under N2, suggesting the absence of recrystallization and melting or presence only decomposition. The IV - FTIR analysis along with PCA analysis and HPLC and thermal data suggest that rifampicin for their fusion is concomitant decomposition of the sample in N2 and fusion events and recrystallization do not occur in synthetic air atmosphere. Decomposition products studied in an air atmosphere showed no melting event and presented simultaneously to the decomposition initiation of heating after process loss of water and / or solvent, varying the Ti initiating events. The Coats - Redfern , Madsudhanan , Van Krevelen and Herwitz - Mertzger kinetic parameters for samples , through the methods of OZAWA , in an atmosphere of synthetic air and / or N2 rifampicin proved more stable than its degradation products . The kinetic data showed good correlation between the different models employed. In this way we contribute to obtaining information that may assist studies of pharmaceutical compatibility and stability of substances / estudada. H? relatos de estudos focando o desenvolvimento de metodologias anal?ticas, novas aplica??es farmac?uticas, bem como, desenvolvimento de novas formas farmac?uticas. A busca pelo entendimento dascaracter?sticas f?sico-qu?micas das subst?ncias tem auxiliado no desenvolvimento de novos produtos farmac?uticos, com seguran?a, efic?cia e qualidade,fornecendo informa??es ?teis sobre s?ntese e armazenamento. Dentre os produtos de decomposi??o j? conhecidos para rifampicina, temos a rifampicina quinona, rifampicina N-?xido e 3-formilrifampicina, para tais, dados t?rmicos s?o escassos na literatura. As t?cnicas t?rmicas v?m sendo utilizadas na ?rea farmac?utica em diversas aplica??es, como na caracteriza??o de f?rmacos, determina??o do grau de pureza, identifica??o de polimorfismo, estudos de estabilidade, compatibilidade e cin?tica de degrada??o. Este trabalho tem como objetivo contribuir com o estudo t?rmico da rifampicina atrav?s das t?cnicas t?rmicas (TG/DTG, DTA, DSC, DSC-Fotovisual)e n?o t?rmicas, e seus principais produtos de degrada??o (rifampicina quinona, rifampicina N-?xido 3-formilrifamicina). A partir de an?lises DSC, DRX e FTIR foi poss?vel caracterizar a rifampicina estudada como polimorfo II. O conjunto de t?cnicas t?rmicas e n?o t?rmicas auxiliaram a verificar que parte da rifamipicina ? decomposta durante o processo de fus?o, em atmosfera de nitrog?nio, bem como que, os eventos de fus?o e recristaliza??o n?o ocorrem em atmosfera de ar sint?tico passando a amostra diretamente a decomposi??o. Os produtos de decomposi??o estudados, quando em atmosfera de ar, n?o apresentaram evento de fus?o e, apresentaram v?rios passos de decomposi??o, com a ocorr?ncia de eventos exot?rmicos e endot?rmicos. A partir de curvas TG din?micas, foi poss?vel calcular os par?metros cin?ticos para as amostras, atrav?s dos m?todos de OZAWA, Coats-Redfern, Madsudhanan, Van Krevelen e Herwitz-Mertzger, em atmosfera de ar sint?tico e/ou nitrog?nio. Os dados cin?ticos mostraram boa correla??o entre os diferentes modelos empregados. Tanto para rifampicina quanto os produtos de degrada??o estudados, foi caracterizado rea??o de ordem um